Tablets
Showing 1 - 25 of >10,000
Gout With Hyperuricemia in Adults Trial (HR091506 tablets + of febuxostat tablets, febuxostat tablets + of HR091506 tablets)
Not yet recruiting
- Gout With Hyperuricemia in Adults
- HR091506 tablets + placebo of febuxostat tablets
- febuxostat tablets + placebo of HR091506 tablets
- (no location specified)
Nov 15, 2023
High-volume, Metastatic, Hormone-sensitive Prostate Cancer (mHSPC) Trial (dalpiciclib isethionate tablets; abiraterone acetate
Not yet recruiting
- High-volume, Metastatic, Hormone-sensitive Prostate Cancer (mHSPC)
- dalpiciclib isethionate tablets; abiraterone acetate tablets; prednisone tablets
- placebo; abiraterone acetate tablets; prednisone tablets
- (no location specified)
Oct 20, 2023
Diabetic Peripheral Neuropathic Pain Trial in Luoyang (HSK16149 20mg BID)
Recruiting
- Diabetic Peripheral Neuropathic Pain
- HSK16149 20mg BID
-
Luoyang, Henan, ChinaThe First Affiliated Hospital of Henan University of Science and
Nov 2, 2023
The Effects of Clarithromycin or Cyclosporine on Pharmacokinetics of Deuterium Hydrobromide Ramidvir Tablets in Healthy Chinese
Active, not recruiting
- The Effects of Clarithromycin or Cyclosporine on Pharmacokinetics of Deuterium Hydrobromide Ramidvir Tablets in Healthy Chinese Subjects
- Mindeudesivir hydrobromide tablets and Clarithromycin tablets
- Mindeudesivir hydrobromide tablets and Cyclosporine softgels
-
Zhengzhou, Henan, ChinaZhengzhou Sixth People's Hospital
Aug 15, 2023
Viral Infection COVID-19 Trial in Saint Petersburg, (Aterixen)
Not yet recruiting
- Viral Infection COVID-19
-
Saint Petersburg,, Russian FederationLimited Liability Company "Research Center Eco-Safety"
Oct 23, 2023
Hyperuricemia Trial (Kui-Yuan Chewable Tablets, Placedo of Kui-Yuan Chewable Tablets)
Not yet recruiting
- Hyperuricemia
- Kui-Yuan Chewable Tablets
- Placedo of Kui-Yuan Chewable Tablets
- (no location specified)
Jun 18, 2023
Healthy Trial in Qingdao (Test Empagliflozin And Linagliptin Tablets, Reference Empagliflozin And Linagliptin tablets)
Completed
- Healthy
- Test Empagliflozin And Linagliptin Tablets
- Reference Empagliflozin And Linagliptin tablets
-
Qingdao, Shandong, ChinaThe Affiliated Hospital of Qingdao University Phase I Clinical R
Jul 14, 2023
Myelofibrosis Trial in Jinan (TQ05105 tablets, Itraconazole capsule, Rifampicin Capsule)
Not yet recruiting
- Myelofibrosis
- TQ05105 tablets
- +2 more
-
Jinan, Shandong, ChinaShandong Provincial Hospital
Aug 30, 2023
Healthy Participants Trial in Overland Park (Treatment A: Emraclidine 30mg IR tablets (reference), Treatment B: Emraclidine 30mg
Not yet recruiting
- Healthy Participants
- Treatment A: Emraclidine 30mg IR tablets (reference)
- +3 more
-
Overland Park, KansasOverland Park, Kansas
Jun 28, 2023
Type 2 Diabetes Trial (hrx0701 tablets?Metformin HCl tablets?Retagliptin phosphate tablets, hrx0701 tablets)
Completed
- Type 2 Diabetes Mellitus
- hrx0701 tablets、Metformin hydrochloride tablets、Retagliptin phosphate tablets
- hrx0701 tablets
-
Changsha, Hunan, ChinaXiangya Third Hospital
Dec 20, 2022
Healthy Trial (Daridorexant 10 mg, Daridorexant 25 mg)
Not yet recruiting
- Healthy
- Daridorexant 10 mg
- Daridorexant 25 mg
- (no location specified)
Jun 1, 2023
Bioequivalence Study Trial in Beijing (Calcium Hydroxybenzene Sulphonate Dispersible Tablets 0.25g, Calcium Hydroxybenzene
Recruiting
- Bioequivalence Study
- Calcium Hydroxybenzene Sulphonate Dispersible Tablets 0.25g
- Calcium Hydroxybenzene Sulfonate Tablets（Doxium®) 250mg
-
Beijing, Beijing, ChinaNational Institue for Drug Clinical Trials
Mar 21, 2023
Hypertension Trial in Dongguan (Felodipine sustained release tablets (trade name: plendil®), Felodipine Controlled Release
Active, not recruiting
- Hypertension
- Felodipine sustained release tablets (trade name: plendil®)
- Felodipine Controlled Release Tablets
-
Dongguan, Guangdong, ChinaClinical Trial Centre of Dongguan Kanghua Hospital
Jan 31, 2023
Biliary Carcinoma Trial in Qingdao (TQB3454 tablets)
Not yet recruiting
- Biliary Carcinoma
- TQB3454 tablets
-
Qingdao, Shandong, ChinaThe Affiliated Hospital of Qingdao University
Nov 15, 2023
NSCLC Trial in Shanghai (SH-1028 tablets, Placebo SH-1028 tablets)
Recruiting
- Non-small Cell Lung Cancer
- SH-1028 tablets
- Placebo SH-1028 tablets
-
Shanghai, Shanghai, ChinaShanghai Pulmonary Hospital
Oct 6, 2023
Partial Seizure Trial in Tianjin (Brivaracetam tablets (50mg/ tablet, BRIVIACT®, UCB), Brivaracetam sustained-release tablets
Active, not recruiting
- Partial Seizure
- Brivaracetam tablets (50mg/ tablet, BRIVIACT®, UCB)
- +2 more
-
Tianjin, Tianjin, ChinaTianjin Municipal People's Hospital
Jan 31, 2023
COVID-19 Pneumonia Trial in Changchun (GST-HG171 Tablets)
Recruiting
- COVID-19 Pneumonia
- GST-HG171 Tablets
-
Changchun, Jilin, ChinaThe first hospital of Jilin University
Oct 26, 2023
COVID-19 Pneumonia Trial in Changchun (GST-HG171 Tablets)
Completed
- COVID-19 Pneumonia
- GST-HG171 Tablets
-
Changchun, Jilin, ChinaThe first hospital of Jilin University
Oct 26, 2023
Chronic Hepatitis B Trial (HRS9950 tablets, HRS9950 tablets)
Not yet recruiting
- Chronic Hepatitis B
- HRS9950 tablets
- HRS9950 placebo tablets
- (no location specified)
Jun 7, 2023
Healthy Volunteers Trial in Changsha (TY-9591 Tablets under Fasted Condition - Arm1, Osimertinib Mesylate Tablets under Fasted
Completed
- Healthy Volunteers
- TY-9591 Tablets under Fasted Condition - Arm1
- +5 more
-
Changsha, Hunan, ChinaHunan Provincial Tumor Hospital
Dec 6, 2022
Healthy Trial (Test (T) Entacapone,Levodopa and Carbidopa Tablets (II), Reference (R) Entacapone,Levodopa and Carbidopa Tablets
Not yet recruiting
- Healthy
- Test (T) Entacapone,Levodopa and Carbidopa Tablets (II)
- Reference (R) Entacapone,Levodopa and Carbidopa Tablets (II)
- (no location specified)
Jul 26, 2023
Rheumatoid Arthritis Trial (VC005 tablets, VC005 Tablets Placebo)
Not yet recruiting
- Rheumatoid Arthritis
- VC005 tablets
- VC005 Tablets Placebo
- (no location specified)
May 24, 2023
Active Ankylosing Spondylitis Trial (VC005 tablets, Tofacitinib Citrate Tablets, VC005 Tablets Placebo)
Not yet recruiting
- Active Ankylosing Spondylitis
- VC005 tablets
- +2 more
- (no location specified)
Apr 4, 2023
Lupus Nephritis Trial (Mescaline sodium enteric-coated tablets, Morte-mescaline, Glucocorticoids)
Not yet recruiting
- Lupus Nephritis
- Mescaline sodium enteric-coated tablets
- +2 more
- (no location specified)
Jul 5, 2023